| Code | 6266D | ||||||||||
| MA number | EU/1/20/1498/003 | ||||||||||
| Product Form: | sus inh 3x120 dávok/5 µg/7,2 µg/160 µg (inh. Al/plast) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | AstraZeneca AB, Sweden | ||||||||||
| Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | pressurised container Al | ||||||||||
| Route of admin.: | Inhalation use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 09.12.2020 |
| Validity: | 09.12.2025 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 18.10.2023 |
